Adenocarcinoma of the esophagogastric junction

Adenocarcinoma of the esophagogastric junction

Schneider, Paul M.

119,55 €(IVA inc.)

Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. This special volume, with contributions from experts in the field, covers all aspects of the disease. Etiology, pathogenesis, classification, and clinical staging are discussed, and there is special emphasis on state of the art treatment techniques. The latter range from endoscopic mucosal resections or limited surgical resections for early cancers to multimodality treatment options for locally advanced tumors. Emerging quality issues in surgical management are addressed. Detailed attention is also paid to other important recent developments, including molecular response prediction, early metabolic response evaluation by PET and PET-CT, the diagnosis of micrometastases, and the use of sentinel node technology. This volume will be of interest to all clinicians concerned with the diagnosis and management of this malignancy. Provides detailed coverage of etiology, pathogenesis, classification, and clinical staging Focuses in particular on state of the art treatment techniques, ranging from endoscopic mucosal resections or limited surgical resections to multimodality treatment options Discusses molecular response prediction, early metabolic response evaluation, the diagnosis of micrometastases, and the use of sentinel node technology INDICE: Epidemiology of adenocarcinoma of the esophagogastric junction (EJ).- Clinical classification systems.- Histopathologic classification.- The pathogenesis of Barrett’s metaplasia and the progression to esophageal adenocarcinoma.- Differences in the molecular biology of adenocarcinoma of the EJ.- Clinical staging.- Endoscopic mucosal resection for staging and therapy.- Surgicalstrategies.- Current status of sentinal lymph node biopsy in adenocarcinoma of the EJ.- Current diagnosis and future impact of micrometastases for therapeutic strategies.- Quality indicators in the surgical management of adenocarcinoma of the EJ.- Perioperative and complication management.- Multimodality therapy.- Metabolic response evaluation by PET during neoadjuvant treatment.- Molecular response prediction in multimodality treatment.

  • ISBN: 978-3-540-70578-9
  • Editorial: Springer
  • Encuadernacion: Cartoné
  • Páginas: 256
  • Fecha Publicación: 04/06/2010
  • Nº Volúmenes: 1
  • Idioma: Inglés